Research Article
Metadichol®: A Novel Nanolipid Formulation That Inhibits SARS-CoV-2 and a Multitude of Pathological Viruses In Vitro
Table 4
Antiviral assay of Metadichol against various viruses, as measured using the neutral red assay.
| | Metadichol (μg/mL) | Adenovirus | Tacaribe | Rift valley fever | SARS | Japanese encephalitis | West Nile | Yellow fever | Powassan |
| | 5 | 100% | 31% | 100% | 0% | 56% | 84% | 70% | 53% | | 1.6 | 100% | 69% | 100% | 52% | 87% | 100% | 73% | 100% | | 0.5 | 100% | 97% | 100% | 100% | 100% | 100% | 95% | 100% | | 0.16 | 100% | 100% | 100% | 100% | 100% | 100% | 96% | 100% | | EC50 | >9.9 | 2.8 | >8.4 | 1.7 | >7.2 | >8.5 | >5 | >5.1 |
|
|
EC50: 50% effective antiviral concentration.
|
